Deep learning for predicting synergistic drug combinations: State-of-the-arts and future directions

被引:2
作者
Wang, Yu [1 ]
Wang, Junjie [2 ]
Liu, Yun [2 ,3 ]
机构
[1] Putuo Dist Ganquan St Community Healthcare Ctr, Shanghai, Peoples R China
[2] Nanjing Med Univ, Sch Biomed Engn & Informat, Dept Med Informat, Nanjing, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Informat, Nanjing 210029, Peoples R China
来源
CLINICAL AND TRANSLATIONAL DISCOVERY | 2024年 / 4卷 / 03期
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
deep learning; drug combination; drug synergy; neural network; HYPERTENSION; NEBIVOLOL; VALSARTAN; IDENTIFY; NETWORK; SAFETY;
D O I
10.1002/ctd2.317
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Combination therapy has emerged as an efficacy strategy for treating complex diseases. Its potential to overcome drug resistance and minimize toxicity makes it highly desirable. However, the vast number of potential drug pairs presents a significant challenge, rendering exhaustive clinical testing impractical. In recent years, deep learning-based methods have emerged as promising tools for predicting synergistic drug combinations. This review aims to provide a comprehensive overview of applying diverse deep-learning architectures for drug combination prediction. This review commences by elucidating the quantitative measures employed to assess drug combination synergy. Subsequently, we delve into the various deep-learning methods currently employed for drug combination prediction. Finally, the review concludes by outlining the key challenges facing deep learning approaches and proposes potential challenges for future research. Combination therapy's efficacy: It's a vital strategy for treating complex diseases, overcoming drug resistance, and minimizing toxicity. Challenge of drug combination: The vast number of potential drug pairs makes exhaustive clinical testing impractical. Deep learning in drug combination prediction: Recent advancements use diverse deep learning architectures to predict synergistic drug combinations, addressing key challenges and suggesting future research directions. image
引用
收藏
页数:12
相关论文
共 83 条
  • [1] A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers
    Alruwaili, Mohammed M.
    Zonneville, Justin
    Naranjo, Maricris N.
    Serio, Hannah
    Melendy, Thomas
    Straubinger, Robert M.
    Gillard, Bryan
    Foster, Barbara A.
    Rajan, Priyanka
    Attwood, Kristopher
    Chatley, Sarah
    Iyer, Renuka
    Fountzilas, Christos
    Bakin, Andrei V.
    [J]. CELL REPORTS MEDICINE, 2024, 5 (03)
  • [2] Trustworthy Deep Neural Network for Inferring Anticancer Synergistic Combinations
    Alsherbiny, Muhammad A.
    Radwan, Ibrahim
    Moustafa, Nour
    Bhuyan, Deep Jyoti
    El-Waisi, Muath
    Chang, Dennis
    Li, Chun Guang
    [J]. IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2023, 27 (04) : 1691 - 1700
  • [3] Trends in Phase II Trials for Cancer Therapies
    Azam, Faruque
    Vazquez, Alexei
    [J]. CANCERS, 2021, 13 (02) : 1 - 16
  • [4] AI-enabled organoids: Construction, analysis, and application
    Bai, Long
    Wu, Yan
    Li, Guangfeng
    Zhang, Wencai
    Zhang, Hao
    Su, Jiacan
    [J]. BIOACTIVE MATERIALS, 2024, 31 : 525 - 548
  • [5] The toxicity of poisons applied jointly
    Bliss, CI
    [J]. ANNALS OF APPLIED BIOLOGY, 1939, 26 (03) : 585 - 615
  • [6] Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
    Bobrowski, Tesia
    Chen, Lu
    Eastman, Richard T.
    Itkin, Zina
    Shinn, Paul
    Chen, Catherine Z.
    Guo, Hui
    Zheng, Wei
    Michael, Sam
    Simeonov, Anton
    Hall, Matthew D.
    Zakharov, Alexey, V
    Muratov, Eugene N.
    [J]. MOLECULAR THERAPY, 2021, 29 (02) : 873 - 885
  • [7] Predicting anticancer synergistic drug combinations based on multi-task learning
    Chen, Danyi
    Wang, Xiaowen
    Zhu, Hongming
    Jiang, Yizhi
    Li, Yulong
    Liu, Qi
    Liu, Qin
    [J]. BMC BIOINFORMATICS, 2023, 24 (01)
  • [8] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS
    CHOU, TC
    TALALAY, P
    [J]. ADVANCES IN ENZYME REGULATION, 1984, 22 : 27 - 55
  • [9] MFSynDCP: multi-source feature collaborative interactive learning for drug combination synergy prediction
    Dong, Yunyun
    Chang, Yunqing
    Wang, Yuxiang
    Han, Qixuan
    Wen, Xiaoyuan
    Yang, Ziting
    Zhang, Yan
    Qiang, Yan
    Wu, Kun
    Fan, Xiaole
    Ren, Xiaoqiang
    [J]. BMC BIOINFORMATICS, 2024, 25 (01)
  • [10] Edwards CN., 2023, Biorxiv, P2007